Displaying 1–1 of 1 results for John Lunger, VP Manufacturing and Supply Chain Development, Adaptimmune

Sort By Relevance Sort By Date

Supply Chain Strategies for New Therapies

(Article)

John Lunger, VP Manufacturing and Supply Chain Development, Adaptimmune on how autologous engineered T-cell therapies challenge traditional late stage and commercial pharma supply chains practices

Sort By Relevance Sort By Date